ArticleOncotarget2018

Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the down-regulation of the androgen receptor.

Yusuke Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.